Trial Profile
Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by the If ("Funny Channel" Current) Inhibitor Ivabradine.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Tachycardia
- Focus Therapeutic Use
- Acronyms MODIfY
- 23 Jan 2013 Status changed from recruiting to completed.
- 04 Sep 2010 New trial record